These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


152 related items for PubMed ID: 17413593

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. PET-CT demonstration of extensive muscle metastases from breast cancer.
    Liu Y, Ghesani N, Mirani N, Zuckier LS.
    Clin Nucl Med; 2006 May; 31(5):266-8. PubMed ID: 16622333
    [No Abstract] [Full Text] [Related]

  • 23. Impact of whole-body imaging on treatment decision to radio-frequency ablation in patients with malignant liver tumors: comparison of [18F]fluorodeoxyglucose-PET/computed tomography, PET and computed tomography.
    Kuehl H, Rosenbaum-Krumme S, Veit-Haibach P, Stergar H, Forsting M, Bockisch A, Antoch G.
    Nucl Med Commun; 2008 Jul; 29(7):599-606. PubMed ID: 18528181
    [Abstract] [Full Text] [Related]

  • 24. Acute intramural hematoma of the aorta as a cause of positive FDG PET/CT.
    Ryan A, McCook B, Sholosh B, Pryma DA, Jablonowski E, Fuhrman C, Blodgett TM.
    Clin Nucl Med; 2007 Sep; 32(9):729-31. PubMed ID: 17710030
    [Abstract] [Full Text] [Related]

  • 25. Combined (18)F-FDG and fluoride approach in PET/CT imaging: is there a clinical future?
    Basu S, Rao R.
    J Nucl Med; 2010 Jan; 51(1):165; author reply 166-7. PubMed ID: 20008984
    [No Abstract] [Full Text] [Related]

  • 26. 18F-FDG-PET/CT findings in a patient with tuberculosis Hodgkin's disease and lupus vulgaris.
    Kaya E, Halac M, Sönmezoglu K, Sager S, Uslu I.
    Hell J Nucl Med; 2009 Jan; 12(3):285-6. PubMed ID: 19936348
    [No Abstract] [Full Text] [Related]

  • 27. Marginal zone lymphoma involving subcutaneous fat: appearance by FDG-PET/CT, MRI, and contrast-enhanced CT imaging.
    Chong EA, Torigian DA, Mato AR, Downs LH, Schuster SJ.
    Clin Nucl Med; 2008 Oct; 33(10):692-3. PubMed ID: 18806570
    [No Abstract] [Full Text] [Related]

  • 28. How do we best balance optimal timing of FDG PET-CT imaging?
    Hofman MS, O'Doherty M.
    Nucl Med Commun; 2007 Dec; 28(12):885-7. PubMed ID: 18090212
    [No Abstract] [Full Text] [Related]

  • 29. PET/CT for the staging and follow-up of patients with malignancies.
    Poeppel TD, Krause BJ, Heusner TA, Boy C, Bockisch A, Antoch G.
    Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
    [Abstract] [Full Text] [Related]

  • 30. F-18 FDG PET/CT in the management of thyroid cancer.
    Iagaru A, Kalinyak JE, McDougall IR.
    Clin Nucl Med; 2007 Sep; 32(9):690-5. PubMed ID: 17710020
    [Abstract] [Full Text] [Related]

  • 31. Fever of unknown origin: the role of 18F-FDG PET/CT.
    Keidar Z, Gurman-Balbir A, Gaitini D, Israel O.
    J Nucl Med; 2008 Dec; 49(12):1980-5. PubMed ID: 18997040
    [Abstract] [Full Text] [Related]

  • 32. Positron emission tomography/computed tomography for staging and restaging of head and neck cancer: comparison with positron emission tomography read together with contrast-enhanced computed tomography.
    Goerres GW, Schuknecht B, Schmid DT, Stoeckli SJ, Hany TF.
    Clin Imaging; 2008 Dec; 32(6):431-7. PubMed ID: 19006770
    [Abstract] [Full Text] [Related]

  • 33. Utility of 18F-FDG-PET/CT imaging in the diagnosis of appendicitis.
    Moghadam-Kia S, Nawaz A, Newberg A, Basu S, Alavi A, Torigian DA.
    Hell J Nucl Med; 2009 Dec; 12(3):281-2. PubMed ID: 19936346
    [No Abstract] [Full Text] [Related]

  • 34. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin.
    Zhang M, Jiang X, Zhang M, Xu H, Zhai G, Li B.
    J Nucl Med; 2009 Apr; 50(4):506-12. PubMed ID: 19289438
    [Abstract] [Full Text] [Related]

  • 35. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer.
    Anjos DA, Etchebehere EC, Ramos CD, Santos AO, Albertotti C, Camargo EE.
    J Nucl Med; 2007 May; 48(5):764-70. PubMed ID: 17475965
    [Abstract] [Full Text] [Related]

  • 36. Chronic sequelae of herpes simplex encephalitis demonstrated on interictal F-18 FDG PET/CT.
    Wong KK, Tolia B, Bohnen N.
    Clin Nucl Med; 2008 Jun; 33(6):443-4. PubMed ID: 18496462
    [No Abstract] [Full Text] [Related]

  • 37. Follow-up of FDG-PET/CT findings in retroperitoneal fibrosis associated with abdominal aortic aneurysm.
    Wiggermann P, Aust D, Stroszczynski C, Kotzerke J, Zöphel K.
    Nuklearmedizin; 2011 Jun; 50(3):N21-2. PubMed ID: 21611677
    [No Abstract] [Full Text] [Related]

  • 38. Isolated facial muscle metastasis from renal cell carcinoma on F-18 FDG PET/CT.
    Kang S, Song BI, Lee HJ, Jeong SY, Seo JH, Lee SW, Ahn BC, Lee J, Lee HJ.
    Clin Nucl Med; 2010 Apr; 35(4):263-4. PubMed ID: 20305417
    [No Abstract] [Full Text] [Related]

  • 39. F-18 FDG PET/CT staging of multiple myeloma with diffuse osseous and extramedullary lesions.
    Wiesenthal AA, Nguyen BD.
    Clin Nucl Med; 2007 Oct; 32(10):797-801. PubMed ID: 17885362
    [Abstract] [Full Text] [Related]

  • 40. Diagnosis and localization of renal cyst infection by 18F-fluorodeoxyglucose PET/CT in polycystic kidney disease.
    Soussan M, Sberro R, Wartski M, Fakhouri F, Pecking AP, Alberini JL.
    Ann Nucl Med; 2008 Jul; 22(6):529-31. PubMed ID: 18670861
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.